AB Science announces that it has filed an application for

PRESS RELEASE AB SCIENCE ANNOUNCES FILING OF MARKETING AUTHORIZATION APPLICATION FOR ALSITEK IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS...

Related Keywords

United States ,Paris ,France General ,France ,Scler Frontotemporal Degener ,Alain Moussy ,European Medicines Agency ,Committee For Medicinal Products Human Use ,Marketing Authorization ,Medicinal Products ,Human Use ,Therapeutic Advances ,Neurological Disorders ,Normal Progressor ,Lateral Scler Frontotemporal ,Survival Analysis ,Amyotrophic Lateral ,Ther Adv Neurol Disord ,Euronext Paris ,Paris Stock Exchange Ab ,Ab Science ,Amyotrophic Lateral Sclerosis ,Lou Gehrig ,Eurology ,Asitinib ,Charcot ,Cl 233 Rose Lat Rale Amyotrophiqu ,